Health · 4 views
Higher ADK levels track stronger triciribine effects in leukemia cells, pointing to a potential biomarker
In a comprehensive study of acute lymphoblastic leukemia, researchers at Karolinska Institutet have shown that the enzyme ADK plays an important role in determining how leukemia cells respond to triciribine.
Summary
In a comprehensive study of acute lymphoblastic leukemia, researchers at Karolinska Institutet have shown that the enzyme ADK plays an important role in determining how leukemia cells respond to triciribine. Published in npj Precision Oncology , the study also provides new insights into how the compound works and identifies ADK as a potential biomarker for predicting its effects on leukemia cells. Acute lymphoblastic leukemia (ALL) is a blood cancer that can affect people of all ages.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Jalen Hurts' devastating diagnosis rattles sports worldContinue reading
- 3D printing method could expand options for personalized cardiovascular devicesContinue reading
- DNA once dismissed as 'noise' reveals new bacterial species in prostate cancer patientsContinue reading
- The Ebola crisis is far outpacing the response, Congo's IRC director saysContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow